Fundraise / allotmentMajor development· Adverse for the businessFiled on BSE ·

Neogen Chemicals Crisil downgrade to A2/A-; Q1 FY27 results; Rs.600 crore fundraise plan

Neogen Chemicals · Chemicals & Petrochemicals

Arthneeti Research DeskPublished 1 min read
₹600 CrFundraise / allotment

Key highlights

  • Crisil downgraded short-term rating to A2 from A1 and long-term to A-/Negative from A/Negative on July 17, 2026; Rs.200 crore NCD coupon rises to 11.00% from 10.50%
  • Unaudited standalone and consolidated results for quarter ended June 30, 2026 approved; standalone profit for the period Rs.19.44 crore vs Rs.14.23 crore a year earlier
  • In-principle approval to raise up to Rs. 600 crore via equity, QIP or other eligible securities, subject to member and regulatory approvals

Why it's rated major development: credit rating downgrade is always high

Figures checked against the filing by a second AI read, which corrected the first summary. About the business, not the share price.

Original filing

Outcome Of Board Meeting

Read the filing on BSE (PDF) →

Companies guiding to strong growth

Ranked by management's own guidance on revenue and margins — not by us.

Rossell Techsys

Aerospace & Defense

Revenue growth 40%+Margin up 2%+

Sign up free to see all 6 →

See full rankings

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

More from Neogen Chemicals

Other fundraise / allotment filings this fortnight

All fundraise / allotment filings →

Summary written by Arthneeti from the company's filing with the stock exchange; check the original filing for full details. Arthneeti is a research and analytics platform, not a SEBI-registered investment adviser, and nothing here is a recommendation to buy or sell.